CAR-T cell therapy manufacturing faces critical challenges in achieving consistent expansion, gene editing efficiency and functional quality across clinical-grade production systems. Traditional serum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback